Sfoglia per AUTORE
GORI S
Collezione ASL Città di Torino

  

Items : 8

Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies. in EClinicalMedicine / EClinicalMedicine. 2023 May 12;59:101931. doi: 10.1016/j.eclinm.2023.101931. eCollection 2023 May.

2023
ASL Città di Torino
AOU Città della Salute di Torino

Del Mastro L; Boni L; Poggio F; de Azambuja E; Gasparini E; Agostinetto E; Sanna V; Caputo R; De Angelis C; Fregatti P; Razeti MG; Urracci Y; Tamberi S; Turletti A; Durando A; Gori S; Frassoldati A; Montemurro F; Russo A; Mansutti M; Michelotti A; Rimanti A; Mura S; De Placido S; Fabi A; De Laurentiis M; Bisagni G; Blondeaux E; Lambertini M; et alii...

SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Dec 15;29(24):5217-5226. doi: 10.1158/1078-0432.CCR-23-1568.

2023
AOU Città della Salute di Torino
ASL Città di Torino
AOU Alessandria

Prat A; Cardinali B; Piccioli P; Serra M; Lastraioli S; Bighin C; Poggio F; Lambertini M; Del Mastro L; Frassoldati A; Porpiglia M; Fabi A; Generali D; Scognamiglio G; Rossi M; Brasó-Maristany F; Puglisi F; Mansutti M; De Angioletti M; Notaro R; Turletti A; Lunardi G; Pazzola A; Ponzone R; Montemurro F; Schettini F; De Placido S; Tamberi S; Gori S; et alii...

Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ?50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy. in Thoracic cancer / Thorac Cancer. 2022 Feb;13(3):483-488. doi: 10.1111/1759-7714.14256. Epub 2021 Dec 22.

2022
ASL Città di Torino
AOU Novara

Cortellini A; Addeo A; Pinato DJ; Porzio G; Ficorella C; Pensieri MV; Friedlaender A; Metro G; De Toma A; Cappuzzo F; Bertolini F; Rijavec E; Citarella F; Cantini L; Mansueto G; Gori S; Macerelli M; Chiari R; Rastelli F; Gelibter A; Mazzoni F; Catino A; Genova C; Morabito A; Grossi F; Berardi R; Bria E; Giusti R; Baldessari C; et alii...

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology. in Breast (Edinburgh, Scotland) / Breast. 2022 Dec;66:293-304. doi: 10.1016/j.breast.2022.10.014. Epub 2022 Oct 29.

2022
ASL Città di Torino
AOU Novara

Levaggi A; Delle Piane C; Biganzoli L; Zambelli A; Del Mastro L; Montemurro F; Criscitiello C; Cortesi L; Dieci MV; Cinquini M; Miglietta F; Marchiò C; Calabrese M; Fortunato L; Franco P; Meduri B; Fittipaldo VA; Gori S;

EP06.01-006 Multidisciplinary Team during the COVID-19 Pandemic: The BE-PACIFIC Italian Observational Study Analysis in Journal of Thoracic Oncology

2022
AOU Città della Salute di Torino
ASL Città di Torino

Ramella S; Morabito A; Silipigni S; Russo A; Capelletto E; Rossi S; Leonetti A; Montrone M; Facilissimo I; Romano G; Stasi I; Ceresoli G; Gridelli C; Lugini A; Pilotto S; Tagliaferri P; Bria E; Canova S; Rijavec E; Borghetti P; Brighenti M; Carta AM; Ciuffreda L; Giusti R; Macerelli M; Verderame F; Zanelli F; Berardi R; Gregorc V; et alii...

EP05.01-024 Real-life Management of Stage III NSCLC Patients in Italy: The BE-PACIFIC Observational Study in Journal of Thoracic Oncology

2022
ASL Città di Torino
AOU Città della Salute di Torino

Novello S; Morabito A; Silipigni S; Adamo V; Bironzo P; Rossi S; Tiseo M; Montrone M; Facilissimo I; Romano G; Stasi I; Ceresoli G; Gridelli C; Lugini A; Pilotto S; Tagliaferri P; Bria E; Cortinovis D; Grossi F; Borghetti P; Brighenti M; Carta AM; Ciuffreda L; Giusti R; Macerelli M; Verderame F; Zanelli F; Berardi R; Gregorc V; et alii...

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.

2020
ASL Cuneo 2
AOU San Luigi di Orbassano
ASL Città di Torino
ASL VCO
AO Ordine Mauriziano
AOU Alessandria

Buti S; Tognetto M; Vaccaro V; Di Costanzo F; Maiello E; Labianca R; Pinto C; Garzoli E; Pilotto S; Castro A; Carrozza F; Gori S; Verusio C; Atzori F; Dicorato AM; Giordano P; Corbo C; Gernone A; Prati V; Carnio S; Tassinari D; Cavanna L; Meriggi F; Longo L; Sartori D; Iannopollo M; Pezzuolo D; Bracarda S; Bonetti A; et alii...

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM). in Cancers / Cancers (Basel). 2019 Aug 8;11(8):1137. doi: 10.3390/cancers11081137.

2019
ASL Città di Torino

Dieci MV; Del Mastro L; Cinquini M; Montemurro F; Biganzoli L; Cortesi L; Zambelli A; Criscitiello C; Levaggi A; Conte B; Calabrese M; Fiorentino A; Marchiò C; Tinterri C; Fittipaldo VA; Pappagallo G; Gori S;